Cargando…

Deriving Immune Modulating Drugs from Viruses—A New Class of Biologics

Viruses are widely used as a platform for the production of therapeutics. Vaccines containing live, dead and components of viruses, gene therapy vectors and oncolytic viruses are key examples of clinically-approved therapeutic uses for viruses. Despite this, the use of virus-derived proteins as natu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaron, Jordan R., Zhang, Liqiang, Guo, Qiuyun, Burgin, Michelle, Schutz, Lauren N., Awo, Enkidia, Wise, Lyn, Krause, Kurt L., Ildefonso, Cristhian J., Kwiecien, Jacek M., Juby, Michael, Rahman, Masmudur M., Chen, Hao, Moyer, Richard W., Alcami, Antonio, McFadden, Grant, Lucas, Alexandra R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230489/ https://www.ncbi.nlm.nih.gov/pubmed/32244484 http://dx.doi.org/10.3390/jcm9040972

Ejemplares similares

Local Serpin Treatment via Chitosan-Collagen Hydrogel after Spinal Cord Injury Reduces Tissue Damage and Improves Neurologic Function
por: Kwiecien, Jacek M., et al.
Publicado: (2020)

Recombinant Myxoma Virus-Derived Immune Modulator M-T7 Accelerates Cutaneous Wound Healing and Improves Tissue Remodeling
por: Yaron, Jordan R., et al.
Publicado: (2020)

Modulation of Tumor Necrosis Factor by Microbial Pathogens
por: Rahman, Masmudur M, et al.
Publicado: (2006)

Modulation of NF-κB signalling by microbial pathogens
por: Rahman, Masmudur M., et al.
Publicado: (2011)

Myxoma Virus dsRNA Binding Protein M029 Inhibits the Type I IFN-Induced Antiviral State in a Highly Species-Specific Fashion
por: Rahman, Masmudur M., et al.
Publicado: (2017)

Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways
por: Rahman, Masmudur M., et al.
Publicado: (2020)

Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020)

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
por: Rahman, Masmudur M., et al.
Publicado: (2021)

Role of cytokines in poxvirus host tropism and adaptation
por: Rahman, Masmudur M, et al.
Publicado: (2022)

Cytokine determinants of viral tropism
por: McFadden, Grant, et al.
Publicado: (2009)

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies
por: Villa, Nancy Y., et al.
Publicado: (2016)

Co-Regulation of NF-κB and Inflammasome-Mediated Inflammatory Responses by Myxoma Virus Pyrin Domain-Containing Protein M013
por: Rahman, Masmudur M., et al.
Publicado: (2009)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells
por: Rahman, Masmudur M., et al.
Publicado: (2017)

Myxoma Virus Protein M029 Is a Dual Function Immunomodulator that Inhibits PKR and Also Conscripts RHA/DHX9 to Promote Expanded Host Tropism and Viral Replication
por: Rahman, Masmudur M., et al.
Publicado: (2013)

Serine Proteases and Chemokines in Neurotrauma: New Targets for Immune Modulating Therapeutics in Spinal Cord Injury
por: Beladi, Roxana N., et al.
Publicado: (2021)

Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma
por: Phelps, Michael P., et al.
Publicado: (2018)

Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma
por: Christie, John D., et al.
Publicado: (2022)

Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma
por: Jazowiecka-Rakus, Joanna, et al.
Publicado: (2022)

RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells
por: Rahman, Masmudur M., et al.
Publicado: (2021)

The Role of Astrogliosis in Formation of the Syrinx in Spinal Cord Injury
por: Kwiecien, Jacek M., et al.
Publicado: (2021)

A Virus-Derived Immune Modulating Serpin Accelerates Wound Closure with Improved Collagen Remodeling
por: Zhang, Liqiang, et al.
Publicado: (2019)

PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion
por: Guo, Qiuyun, et al.
Publicado: (2021)

Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells
por: Bartee, Eric, et al.
Publicado: (2012)

NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy
por: Cornejo, Yvonne, et al.
Publicado: (2020)

Neuroprotective Effect of Subdural Infusion of Serp-1 in Spinal Cord Trauma
por: Kwiecien, Jacek M., et al.
Publicado: (2020)

Myxoma Virus Targets Primary Human Leukemic Stem and Progenitor Cells While Sparing Normal Hematopoietic Stem and Progenitor Cells
por: Kim, Manbok, et al.
Publicado: (2009)

Prolonged inflammation leads to ongoing damage after spinal cord injury
por: Kwiecien, Jacek M., et al.
Publicado: (2020)

The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase
por: Woo, Yanghee, et al.
Publicado: (2021)

Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms
por: Yaron, Jordan R., et al.
Publicado: (2021)

Killing a Killer: What Next for Smallpox?
por: McFadden, Grant
Publicado: (2010)

Poxvirus tropism
por: McFadden, Grant
Publicado: (2005)

The Curious Road from Basic Pathogen Research to Clinical Translation
por: McFadden, Grant
Publicado: (2015)

Passing the Torch
por: McFadden, Grant
Publicado: (2020)

Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma
por: Jazowiecka-Rakus, Joanna, et al.
Publicado: (2020)

Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma
por: Jazowiecka-Rakus, Joanna, et al.
Publicado: (2021)

Analysis of Vaccinia Virus−Host Protein−Protein Interactions: Validations of Yeast Two-Hybrid Screenings
por: Zhang, Leiliang, et al.
Publicado: (2009)

Convergent Loss of the Necroptosis Pathway in Disparate Mammalian Lineages Shapes Viruses Countermeasures
por: Águeda-Pinto, Ana, et al.
Publicado: (2021)

RIG-I Mediates the Co-Induction of Tumor Necrosis Factor and Type I Interferon Elicited by Myxoma Virus in Primary Human Macrophages
por: Wang, Fuan, et al.
Publicado: (2008)

PLoS Pathogens at Three Years
por: Haldar, Kasturi, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_j57n8lu8lu0np40e75snheirad